These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 16488033)

  • 21. "Pathogen-mimicking" nanoparticles for vaccine delivery to dendritic cells.
    Elamanchili P; Lutsiak CM; Hamdy S; Diwan M; Samuel J
    J Immunother; 2007; 30(4):378-95. PubMed ID: 17457213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Active targeting schemes for nanoparticle systems in cancer therapeutics.
    Byrne JD; Betancourt T; Brannon-Peppas L
    Adv Drug Deliv Rev; 2008 Dec; 60(15):1615-26. PubMed ID: 18840489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inorganic hollow nanoparticles and nanotubes in nanomedicine Part 1. Drug/gene delivery applications.
    Son SJ; Bai X; Lee SB
    Drug Discov Today; 2007 Aug; 12(15-16):650-6. PubMed ID: 17706547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Use of nanoparticles for drug delivery in glioblastoma multiforme.
    Jain KK
    Expert Rev Neurother; 2007 Apr; 7(4):363-72. PubMed ID: 17425491
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Cytokine adsorption/release on uniform magnetic nanoparticles for localized drug delivery.
    Mejías R; Costo R; Roca AG; Arias CF; Veintemillas-Verdaguer S; González-Carreño T; del Puerto Morales M; Serna CJ; Mañes S; Barber DF
    J Control Release; 2008 Sep; 130(2):168-74. PubMed ID: 18588929
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Anticancer drug delivery with nanoparticles.
    Conti M; Tazzari V; Baccini C; Pertici G; Serino LP; De Giorgi U
    In Vivo; 2006; 20(6A):697-701. PubMed ID: 17203748
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Nanoparticles in medicine: therapeutic applications and developments.
    Zhang L; Gu FX; Chan JM; Wang AZ; Langer RS; Farokhzad OC
    Clin Pharmacol Ther; 2008 May; 83(5):761-9. PubMed ID: 17957183
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Fabrication of solid nanoparticles for drug delivery.
    Arayne MS; Sultana N; Noor-Us-Sabah
    Pak J Pharm Sci; 2007 Jul; 20(3):251-9. PubMed ID: 17545113
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
    Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
    Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Vancomycin-modified nanoparticles for efficient targeting and preconcentration of Gram-positive and Gram-negative bacteria.
    Kell AJ; Stewart G; Ryan S; Peytavi R; Boissinot M; Huletsky A; Bergeron MG; Simard B
    ACS Nano; 2008 Sep; 2(9):1777-88. PubMed ID: 19206416
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Past and future evolution in colloidal drug delivery systems.
    Boyd BJ
    Expert Opin Drug Deliv; 2008 Jan; 5(1):69-85. PubMed ID: 18095929
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Nanoparticle formation from probucol/PVP/sodium alkyl sulfate co-ground mixture.
    Wanawongthai C; Pongpeerapat A; Higashi K; Tozuka Y; Moribe K; Yamamoto K
    Int J Pharm; 2009 Jul; 376(1-2):169-75. PubMed ID: 19409462
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced surface attachment of protein-type targeting ligands to poly(lactide-co-glycolide) nanoparticles using variable expression of polymeric acid functionality.
    McCarron PA; Marouf WM; Donnelly RF; Scott C
    J Biomed Mater Res A; 2008 Dec; 87(4):873-84. PubMed ID: 18228271
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Biofunctional polymer nanoparticles for intra-articular targeting and retention in cartilage.
    Rothenfluh DA; Bermudez H; O'Neil CP; Hubbell JA
    Nat Mater; 2008 Mar; 7(3):248-54. PubMed ID: 18246072
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Review: nanoparticles in delivery of cardiovascular drugs.
    Arayne MS; Sultana N; Qureshi F
    Pak J Pharm Sci; 2007 Oct; 20(4):340-8. PubMed ID: 17604260
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Masking and triggered unmasking of targeting ligands on nanocarriers to improve drug delivery to brain tumors.
    McNeeley KM; Karathanasis E; Annapragada AV; Bellamkonda RV
    Biomaterials; 2009 Aug; 30(23-24):3986-95. PubMed ID: 19427688
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Synergistically integrated nanoparticles as multimodal probes for nanobiotechnology.
    Cheon J; Lee JH
    Acc Chem Res; 2008 Dec; 41(12):1630-40. PubMed ID: 18698851
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Nanoparticles in cellular drug delivery.
    Faraji AH; Wipf P
    Bioorg Med Chem; 2009 Apr; 17(8):2950-62. PubMed ID: 19299149
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Targeted delivery of antisense oligodeoxynucleotide and small interference RNA into lung cancer cells.
    Li SD; Huang L
    Mol Pharm; 2006; 3(5):579-88. PubMed ID: 17009857
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Shedding light on tumors using nanoparticles.
    Rao J
    ACS Nano; 2008 Oct; 2(10):1984-6. PubMed ID: 19206441
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.